(SJM) The J. M. Smucker - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US8326964058
Coffee, Peanut Butter, Pet Food, Frozen Snacks
Dividends
| Dividend Yield | 4.29% |
| Yield on Cost 5y | 4.54% |
| Yield CAGR 5y | 4.71% |
| Payout Consistency | 97.6% |
| Payout Ratio | 48.9% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 24.5% |
| Value at Risk 5%th | 37.8% |
| Relative Tail Risk | -6.06% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.22 |
| Alpha | -14.79 |
| CAGR/Max DD | -0.28 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.311 |
| Beta | 0.244 |
| Beta Downside | 0.339 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.66% |
| Mean DD | 20.93% |
| Median DD | 23.89% |
Description: SJM The J. M. Smucker October 31, 2025
The J. M. Smucker Company (NYSE:SJM) manufactures and markets a broad portfolio of branded food and beverage products worldwide, organized into four operating segments: U.S. Retail Coffee; U.S. Retail Frozen Handheld and Spreads; U.S. Retail Pet Foods; and Sweet Baked Snacks. Its well-known brands include Folgers, Café Bustelo, Dunkin’, Jif, Smucker’s, Meow Mix, Milk-Bone, Hostess, and Five Roses, among others, and the company reaches consumers through a mix of direct sales, brokers, and a wide array of retail channels from supermarkets to online platforms.
Key recent metrics indicate that Smucker generated approximately $8.5 billion in net sales for FY 2023, with the Pet Foods segment delivering the strongest growth-about 7 % year-over-year-driven by premiumization trends and higher pet-owner spending. Conversely, the Coffee segment faced margin pressure due to rising coffee bean prices and inflationary input costs, a sector-wide challenge reflected in a 3 % decline in operating margin. A broader industry driver is the ongoing shift toward private-label and value-oriented products, which pressures branded snack margins, while the “snackification” of meals continues to support demand for the company’s frozen handheld and baked snack lines.
For a deeper quantitative view of SJM’s valuation metrics and scenario analysis, you may find ValueRay’s platform useful.
Piotroski VR‑10 (Strict, 0-10) 1.5
| Net Income (-1.19b TTM) > 0 and > 6% of Revenue (6% = 526.4m TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA -0.96pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -3.43% (prev -17.07%; Δ 13.64pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 969.2m > Net Income -1.19b (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 0.89 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (106.9m) change vs 12m ago 0.19% (target <= -2.0% for YES) |
| Gross Margin 33.72% (prev 38.72%; Δ -5.01pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 46.61% (prev 44.11%; Δ 2.49pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -1.86 (EBITDA TTM -188.5m / Interest Expense TTM 382.4m) >= 6 (WARN >= 3) |
Altman Z'' -0.25
| (A) -0.02 = (Total Current Assets 2.33b - Total Current Liabilities 2.63b) / Total Assets 17.63b |
| (B) 0.03 = Retained Earnings (Balance) 468.2m / Total Assets 17.63b |
| (C) -0.04 = EBIT TTM -712.5m / Avg Total Assets 18.82b |
| (D) 0.03 = Book Value of Equity 312.2m / Total Liabilities 11.57b |
| Total Rating: -0.25 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 40.36
| 1. Piotroski 1.50pt |
| 2. FCF Yield 3.44% |
| 3. FCF Margin 7.24% |
| 4. Debt/Equity 1.31 |
| 5. Debt/Ebitda -41.65 |
| 6. ROIC - WACC (= -8.21)% |
| 7. RoE -19.12% |
| 8. Rev. Trend 43.26% |
| 9. EPS Trend 12.91% |
What is the price of SJM shares?
As of December 14, 2025, the stock is trading at USD 101.57 with a total of 1,012,097 shares traded.
Over the past week, the price has changed by +1.46%, over one month by -6.59%, over three months by -4.83% and over the past year by -6.88%.
Over the past week, the price has changed by +1.46%, over one month by -6.59%, over three months by -4.83% and over the past year by -6.88%.
Is SJM a buy, sell or hold?
The J. M. Smucker has received a consensus analysts rating of 3.55.
Therefor, it is recommend to hold SJM.
- Strong Buy: 5
- Buy: 2
- Hold: 12
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the SJM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 116.1 | 14.3% |
| Analysts Target Price | 116.1 | 14.3% |
| ValueRay Target Price | 104.1 | 2.5% |
SJM Fundamental Data Overview December 12, 2025
Market Cap USD = 10.64b (10.64b USD * 1.0 USD.USD)
P/E Forward = 11.1359
P/S = 1.2122
P/B = 1.7549
P/EG = 1.6776
Beta = 0.21
Revenue TTM = 8.77b USD
EBIT TTM = -712.5m USD
EBITDA TTM = -188.5m USD
Long Term Debt = 7.04b USD (from longTermDebt, last quarter)
Short Term Debt = 748.2m USD (from shortTermDebt, last quarter)
Debt = 7.91b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.85b USD (from netDebt column, last quarter)
Enterprise Value = 18.49b USD (10.64b + Debt 7.91b - CCE 62.8m)
Interest Coverage Ratio = -1.86 (Ebit TTM -712.5m / Interest Expense TTM 382.4m)
FCF Yield = 3.44% (FCF TTM 635.5m / Enterprise Value 18.49b)
FCF Margin = 7.24% (FCF TTM 635.5m / Revenue TTM 8.77b)
Net Margin = -13.61% (Net Income TTM -1.19b / Revenue TTM 8.77b)
Gross Margin = 33.72% ((Revenue TTM 8.77b - Cost of Revenue TTM 5.82b) / Revenue TTM)
Gross Margin QoQ = 33.56% (prev 22.46%)
Tobins Q-Ratio = 1.05 (Enterprise Value 18.49b / Total Assets 17.63b)
Interest Expense / Debt = 1.25% (Interest Expense 98.6m / Debt 7.91b)
Taxrate = 24.21% (77.1m / 318.4m)
NOPAT = -540.0m (EBIT -712.5m * (1 - 24.21%)) [loss with tax shield]
Current Ratio = 0.89 (Total Current Assets 2.33b / Total Current Liabilities 2.63b)
Debt / Equity = 1.31 (Debt 7.91b / totalStockholderEquity, last quarter 6.06b)
Debt / EBITDA = -41.65 (negative EBITDA) (Net Debt 7.85b / EBITDA -188.5m)
Debt / FCF = 12.35 (Net Debt 7.85b / FCF TTM 635.5m)
Total Stockholder Equity = 6.24b (last 4 quarters mean from totalStockholderEquity)
RoA = -6.77% (Net Income -1.19b / Total Assets 17.63b)
RoE = -19.12% (Net Income TTM -1.19b / Total Stockholder Equity 6.24b)
RoCE = -5.36% (EBIT -712.5m / Capital Employed (Equity 6.24b + L.T.Debt 7.04b))
RoIC = -3.84% (negative operating profit) (NOPAT -540.0m / Invested Capital 14.07b)
WACC = 4.37% (E(10.64b)/V(18.55b) * Re(6.92%) + D(7.91b)/V(18.55b) * Rd(1.25%) * (1-Tc(0.24)))
Discount Rate = 6.92% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 2.17%
[DCF Debug] Terminal Value 78.86% ; FCFE base≈746.7m ; Y1≈776.8m ; Y5≈892.0m
Fair Price DCF = 146.8 (DCF Value 15.66b / Shares Outstanding 106.7m; 5y FCF grow 4.24% → 3.0% )
EPS Correlation: 12.91 | EPS CAGR: -2.73% | SUE: 0.0 | # QB: 0
Revenue Correlation: 43.26 | Revenue CAGR: 3.38% | SUE: 0.53 | # QB: 0
EPS next Quarter (2026-01-31): EPS=2.26 | Chg30d=-0.188 | Revisions Net=-13 | Analysts=14
EPS current Year (2026-04-30): EPS=9.00 | Chg30d=-0.106 | Revisions Net=-10 | Growth EPS=-11.1% | Growth Revenue=+3.9%
EPS next Year (2027-04-30): EPS=8.00 | Chg30d=+0.248 | Revisions Net=+0 | Growth EPS=+23.4% | Growth Revenue=+2.2%
P/E Forward = 11.1359
P/S = 1.2122
P/B = 1.7549
P/EG = 1.6776
Beta = 0.21
Revenue TTM = 8.77b USD
EBIT TTM = -712.5m USD
EBITDA TTM = -188.5m USD
Long Term Debt = 7.04b USD (from longTermDebt, last quarter)
Short Term Debt = 748.2m USD (from shortTermDebt, last quarter)
Debt = 7.91b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.85b USD (from netDebt column, last quarter)
Enterprise Value = 18.49b USD (10.64b + Debt 7.91b - CCE 62.8m)
Interest Coverage Ratio = -1.86 (Ebit TTM -712.5m / Interest Expense TTM 382.4m)
FCF Yield = 3.44% (FCF TTM 635.5m / Enterprise Value 18.49b)
FCF Margin = 7.24% (FCF TTM 635.5m / Revenue TTM 8.77b)
Net Margin = -13.61% (Net Income TTM -1.19b / Revenue TTM 8.77b)
Gross Margin = 33.72% ((Revenue TTM 8.77b - Cost of Revenue TTM 5.82b) / Revenue TTM)
Gross Margin QoQ = 33.56% (prev 22.46%)
Tobins Q-Ratio = 1.05 (Enterprise Value 18.49b / Total Assets 17.63b)
Interest Expense / Debt = 1.25% (Interest Expense 98.6m / Debt 7.91b)
Taxrate = 24.21% (77.1m / 318.4m)
NOPAT = -540.0m (EBIT -712.5m * (1 - 24.21%)) [loss with tax shield]
Current Ratio = 0.89 (Total Current Assets 2.33b / Total Current Liabilities 2.63b)
Debt / Equity = 1.31 (Debt 7.91b / totalStockholderEquity, last quarter 6.06b)
Debt / EBITDA = -41.65 (negative EBITDA) (Net Debt 7.85b / EBITDA -188.5m)
Debt / FCF = 12.35 (Net Debt 7.85b / FCF TTM 635.5m)
Total Stockholder Equity = 6.24b (last 4 quarters mean from totalStockholderEquity)
RoA = -6.77% (Net Income -1.19b / Total Assets 17.63b)
RoE = -19.12% (Net Income TTM -1.19b / Total Stockholder Equity 6.24b)
RoCE = -5.36% (EBIT -712.5m / Capital Employed (Equity 6.24b + L.T.Debt 7.04b))
RoIC = -3.84% (negative operating profit) (NOPAT -540.0m / Invested Capital 14.07b)
WACC = 4.37% (E(10.64b)/V(18.55b) * Re(6.92%) + D(7.91b)/V(18.55b) * Rd(1.25%) * (1-Tc(0.24)))
Discount Rate = 6.92% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 2.17%
[DCF Debug] Terminal Value 78.86% ; FCFE base≈746.7m ; Y1≈776.8m ; Y5≈892.0m
Fair Price DCF = 146.8 (DCF Value 15.66b / Shares Outstanding 106.7m; 5y FCF grow 4.24% → 3.0% )
EPS Correlation: 12.91 | EPS CAGR: -2.73% | SUE: 0.0 | # QB: 0
Revenue Correlation: 43.26 | Revenue CAGR: 3.38% | SUE: 0.53 | # QB: 0
EPS next Quarter (2026-01-31): EPS=2.26 | Chg30d=-0.188 | Revisions Net=-13 | Analysts=14
EPS current Year (2026-04-30): EPS=9.00 | Chg30d=-0.106 | Revisions Net=-10 | Growth EPS=-11.1% | Growth Revenue=+3.9%
EPS next Year (2027-04-30): EPS=8.00 | Chg30d=+0.248 | Revisions Net=+0 | Growth EPS=+23.4% | Growth Revenue=+2.2%
Additional Sources for SJM Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle